Abbott Laboratories Stock Target Price and Analyst Consensus

ABT
 Stock
  

USD 110.22  1.57  1.45%   

The current analyst and expert consensus on Abbott Laboratories is Buy, with 0 strong sell and 11 strong buy opinions. The current projected Abbott Laboratories target price consensus is 140.33 with 12 analyst opinions. The most common way Abbott Laboratories analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Abbott Laboratories executives and customers to further validate their buy or sell advice. Abbott Laboratories buy-or-sell recommendation module provides average expert sentiment on the projected Abbott Laboratories target price to derive its highest and lowest estimates based on projected price volatility of 9.754. Please continue to Macroaxis Advice on Abbott Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
Gross Profit is likely to drop to about 21.4 B in 2022. Profit Margin is likely to drop to 0.14 in 2022. Abbott Laboratories Liabilities Non Current is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Liabilities Non Current of 26.07 Billion in 2021

Abbott Laboratories Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abbott target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abbott target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions14
Lowered Outlook0
Raized Outlook0
Buy
Most Abbott analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abbott stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abbott Laboratories, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Abbott Laboratories Target Price Projection

Abbott Laboratories' current and average target prices are 110.22 and 140.33, respectively. The current price of Abbott Laboratories is the price at which Abbott Laboratories is currently trading. On the other hand, Abbott Laboratories' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Abbott Laboratories Market Quote on 4th of July 2022

Low Price107.67Odds
High Price110.47Odds

110.22

Target Price

Analyst Consensus On Abbott Laboratories Target Price

Low Estimate125.0Odds
High Estimate157.0Odds
Number of Analysts12
Standard Deviation9.754

140.333

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Abbott Laboratories and the information provided on this page.

Abbott Laboratories Analyst Ratings

Abbott Laboratories' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Abbott Laboratories stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Abbott Laboratories' financials, market performance, and future outlook by experienced professionals. Abbott Laboratories' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Abbott Laboratories Target Price Projections

Abbott Laboratories's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Abbott Laboratories and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Abbott depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Abbott Laboratories including analysis of its current option contracts.
Abbott Laboratories' latest option contracts expiring on 2022-07-08 are carrying combined implied volatility of 12.45 with a put-to-call open interest ratio of 0.79 over 104 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2022-07-08. The current put volume is at 91, with calls trading at the volume of 945. This yields a 0.1 put-to-call volume ratio. The Abbott Laboratories option chain provides detailed quote and price information for the current Abbott Laboratories option contracts. It shows all of Abbott Laboratories' listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2022-07-08 Option Contracts

Abbott Laboratories option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Abbott Laboratories' lending market. For example, when Abbott Laboratories' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Abbott Laboratories, he or she must hedge the risk by shorting Abbott Laboratories stock over its option's life.
The chart above shows Abbott Laboratories' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Abbott Laboratories' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Abbott Laboratories' option, there is no secondary market available for investors to trade.

Abbott Laboratories Maximum Pain Price across 2022-07-08 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Abbott Laboratories close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Abbott Laboratories' stock options are financial instruments that give investors the right to buy or sell shares of Abbott Laboratories common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Abbott stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Abbott Laboratories' stock price goes up or down, the stock options follow.
Please continue to Macroaxis Advice on Abbott Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Abbott Laboratories In The Money Call Balance

When Abbott Laboratories' strike price is surpassing the current stock price, the option contract against Abbott Laboratories stock is said to be in the money. When it comes to buying Abbott Laboratories' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' options written on Abbott Laboratories are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Abbott Current Options Market Mood

Abbott Laboratories' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Abbott Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Abbott Laboratories' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Abbott Laboratories' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Abbott Laboratories' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Abbott Laboratories Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Abbott Laboratories is a key component of Abbott Laboratories valuation and have some predictive power on the future returns of a Abbott Laboratories.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbott Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
108.30110.20112.10
Details
Intrinsic
Valuation
LowReal ValueHigh
99.20125.90127.80
Details
Naive
Forecast
LowNext ValueHigh
115.84117.74119.64
Details
Earnings
Estimates (8)
LowProjected EPSHigh
5.045.065.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbott Laboratories.

Additional Abbott Laboratories Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Abbott Laboratories is a key component of Abbott Laboratories valuation and have some predictive power on the future returns of a Abbott Laboratories.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Abbott Laboratories' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Abbott Laboratories in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
108.30110.20112.10
Details
Intrinsic
Valuation
LowReal ValueHigh
99.20125.90127.80
Details
Naive
Forecast
LowNext ValueHigh
115.84117.74119.64
Details
Earnings
Estimates (8)
LowProjected EPSHigh
5.045.065.10
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Abbott Laboratories. Your research has to be compared to or analyzed against Abbott Laboratories' peers to derive any actionable benefits. When done correctly, Abbott Laboratories' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Abbott Laboratories.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Healthcare
Invested less than 1 share
Macroaxis Index
Invested few shares
Artificial Intelligence
Invested few shares
Investor Favorites
Invested less than 1 share
Please continue to Macroaxis Advice on Abbott Laboratories to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
The data published in Abbott Laboratories' official financial statements usually reflect Abbott Laboratories' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Abbott Laboratories. For example, before you start analyzing numbers published by Abbott accountants, it's critical to develop an understanding of what Abbott Laboratories' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Abbott Laboratories' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Abbott Laboratories' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Abbott Laboratories' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Abbott Laboratories. Please utilize our Beneish M Score to check the likelihood of Abbott Laboratories' management to manipulate its earnings.